GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Par Drugs and Chemicals Ltd (NSE:PAR) » Definitions » Shares Outstanding (EOP)

Par Drugs and Chemicals (NSE:PAR) Shares Outstanding (EOP) : 12.3 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Par Drugs and Chemicals Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Par Drugs and Chemicals's shares outstanding for the quarter that ended in Mar. 2024 was 12.3 Mil.

Par Drugs and Chemicals's quarterly shares outstanding increased from Dec. 2023 (12.3 Mil) to Mar. 2024 (12.3 Mil). It means Par Drugs and Chemicals issued new shares from Dec. 2023 to Mar. 2024 .

Par Drugs and Chemicals's annual shares outstanding increased from Mar. 2023 (12.3 Mil) to Mar. 2024 (12.3 Mil). It means Par Drugs and Chemicals issued new shares from Mar. 2023 to Mar. 2024 .


Par Drugs and Chemicals Shares Outstanding (EOP) Historical Data

The historical data trend for Par Drugs and Chemicals's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Par Drugs and Chemicals Shares Outstanding (EOP) Chart

Par Drugs and Chemicals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shares Outstanding (EOP)
Get a 7-Day Free Trial 12.30 12.30 12.30 12.30 12.31

Par Drugs and Chemicals Quarterly Data
Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.30 12.30 12.32 12.31 12.32

Competitive Comparison of Par Drugs and Chemicals's Shares Outstanding (EOP)

For the Drug Manufacturers - Specialty & Generic subindustry, Par Drugs and Chemicals's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Par Drugs and Chemicals's Shares Outstanding (EOP) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Par Drugs and Chemicals's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Par Drugs and Chemicals's Shares Outstanding (EOP) falls into.



Par Drugs and Chemicals Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Par Drugs and Chemicals  (NSE:PAR) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Par Drugs and Chemicals Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Par Drugs and Chemicals's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Par Drugs and Chemicals (NSE:PAR) Business Description

Traded in Other Exchanges
N/A
Address
Gotri Vasna Road, 816, Nilamber Triumph, Vadodara, GJ, IND, 390007
Par Drugs and Chemicals Ltd is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for the domestic market as well as for exports to international markets. APIs are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage.